{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:49:12Z","timestamp":1784242152169,"version":"3.55.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T00:00:00Z","timestamp":1459123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0150625","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T13:37:22Z","timestamp":1459172242000},"page":"e0150625","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Perioperative Use of Clevidipine: A Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"11","author":[{"given":"Angel","family":"Espinosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ripoll\u00e9s\u2013Melchor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Casans-Franc\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Abad-Gurumeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio D.","family":"Bergese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix","family":"Zuleta-Alarcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"L\u00f3pez-Timoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Calvo-Vecino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Evidence Anesthesia Review Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.19070\/2332-2780-130006","article-title":"Innovative approaches to the management of acute arterial hypertension\u2014clevidipine butyrate","volume":"1.4","author":"L Kurnutala","year":"2013","journal-title":"Int J Anesthesiol"},{"issue":"10","key":"ref2","first-page":"557","article-title":"The role of clevidipine in hypertension management: clinical results","volume":"61","author":"A Zuleta-Alarcon","year":"2014","journal-title":"Rev Esp Anestesiol Reanim"},{"key":"ref3","article-title":"ACuTE CARE EVAluATIoN ANd MANAGEMENT","volume":"3","author":"CV Pollack Jr","year":"2008","journal-title":"Emergency Medicine Cardiac Research and Education Group"},{"key":"ref4","first-page":"457","article-title":"Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review","volume":"6","author":"AS Awad","year":"2010","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1213\/ANE.0b013e31820f9231","article-title":"Does perioperative systolic blood pressure variability predict mortality after cardiac surgery? An exploratory analysis of the ECLIPSE trials","volume":"113","author":"S Aronson","year":"2011","journal-title":"Anesth Analg"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1592\/phco.30.5.515","article-title":"Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension","volume":"30","author":"AL Erickson","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1053-0770(97)90166-X","article-title":"A randomized multicenter double-blind comparison of urapidil and ketanserin in hypertensive patients after coronary artery surgery","volume":"11","author":"JG van der Stroom","year":"1997","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/CRD.0b013e31819fe23c","article-title":"Clevidipine: a novel ultra-short-acting calcium antagonist","volume":"17","author":"L Prlesi","year":"2009","journal-title":"Cardiol Rev"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.amjmed.2003.08.027","article-title":"Calcium channel blockers: an update","volume":"116","author":"MJ Eisenberg","year":"2004","journal-title":"Am J Med"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/14656560903499293","article-title":"Clevidipine butyrate: a promising new drug for the management of acute hypertension","volume":"11","author":"SD Bergese","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"72","key":"ref11","first-page":"375","article-title":"Advances in management of acute hypertension: a concise review","volume":"13","author":"DB Tulman","year":"2012","journal-title":"Discov Med"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1213\/01.ane.0000281443.13712.b9","article-title":"Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1","volume":"105","author":"JH Levy","year":"2007","journal-title":"Anesth Analg"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1213\/ane.0b013e3181732e53","article-title":"Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial","volume":"107","author":"N Singla","year":"2008","journal-title":"Anesth Analg"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1213\/ane.0b013e31818240db","article-title":"The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients","volume":"107","author":"S Aronson","year":"2008","journal-title":"Anesth Analg"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"D Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"ref16","author":"J Higgins","year":"2011"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"JC Jakobsen","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"D Moher","year":"2015","journal-title":"Syst Rev"},{"key":"ref19","article-title":"Review Manager (RevMan) [Computer program]. Version 5.2","year":"2012"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v049.i05","article-title":"Closing the gap between methodologists and end-users: R as a computational back-end","volume":"49","author":"BC Wallace","year":"2012","journal-title":"J Stat Softw"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"7414","key":"ref22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ"},{"issue":"5","key":"ref23","first-page":"630","article-title":"The GRADE system: a change in the way of assessing the quality of evidence and the strength of recommendations","volume":"142","author":"I Neumann","year":"2014","journal-title":"Rev Med Chil"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2288-14-34","article-title":"The thresholds for statistical and clinical significance\u2014a five-step procedure for evaluation of intervention effects in randomised clinical trials","volume":"14","author":"JC Jakobsen","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1399-6576.1993.tb03819.x","article-title":"The ideal agent for perioperative hypertension and potential cytoprotective effects","volume":"99","author":"JH Levy","year":"1993","journal-title":"Acta Anaesthesiol Scand Suppl"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11906-009-0031-8","article-title":"Strategies for managing perioperative hypertension","volume":"11","author":"RG Desai","year":"2009","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00003495-200868030-00003","article-title":"Treatment of acute severe hypertension: current and newer agents","volume":"68","author":"J Varon","year":"2008","journal-title":"Drugs"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11906-014-0450-z","article-title":"Current and newer agents for hypertensive emergencies","volume":"16","author":"Ramos A Padilla","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"ref29","unstructured":"Cleviprex (clevidipine butyrate) [package insert]. Parsipanny NT, 2008 MC."},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1520-636X(2001)13:3<130::AID-CHIR1009>3.0.CO;2-2","article-title":"Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients","volume":"13","author":"H Ericsson","year":"2001","journal-title":"Chirality"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0928-0987(98)00058-X","article-title":"In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man","volume":"8","author":"H Ericsson","year":"1999","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2125.1999.00933.x","article-title":"Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers","volume":"47","author":"H Ericsson","year":"1999","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s002280050594","article-title":"Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion","volume":"55","author":"H Ericsson","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00005344-199908000-00013","article-title":"Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans","volume":"34","author":"JH Schwieler","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.4137\/CMT.S6250","article-title":"Safety and Efficacy of Intravenous Clevidipine for the Perioperative Control of Acute Hypertension","volume":"3","author":"Cv Murphy","year":"2011","journal-title":"Clinical Medicine Insights Therapeutics"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1527-3466.2004.tb00143.x","article-title":"Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control","volume":"22","author":"M Nordlander","year":"2004","journal-title":"Cardiovasc Drug Rev"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1213\/00000539-199706000-00012","article-title":"Nicardipine versus nitroprusside for controlled hypotension during spinal surgery in adolescents","volume":"84","author":"SL Hersey","year":"1997","journal-title":"Anesth Analg"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1034\/j.1399-6576.2000.440210.x","article-title":"Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery","volume":"44","author":"N Kieler-Jensen","year":"2000","journal-title":"Acta Anaesthesiol Scand"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00003643-200309000-00004","article-title":"Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgery","volume":"20","author":"AV Powroznyk","year":"2003","journal-title":"Eur J Anaesthesiol"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12630-014-0131-z","article-title":"Clevidipine compared with nitroglycerin for blood pressure control in coronary artery bypass grafting: a randomized double-blind study","volume":"61","author":"AF Merry","year":"2014","journal-title":"Can J Anaesth"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0150625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:22:24Z","timestamp":1588983744000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0150625"}},"subtitle":[],"editor":[{"given":"Yoshihiro","family":"Fukumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,28]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0150625","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,28]]}}}